During the past decade, Hôpital Tenon conducted 201 clinical trials. In the 10-year time frame, 201 clinical trials started and 42 clinical trials were completed, i.e. on average, 20.9% percent of trials that started reached the finish line to date. In the past 5 years, 90 clinical trials started and 24 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Tenon" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 36 trials, followed by "GERCOR - Multidisciplinary Oncology Cooperative Group" with 34 trials sponsored, "UNICANCER" with 28 trials sponsored, "ANRS, Emerging Infectious Diseases" with 12 trials sponsored and "Gilead Sciences" with 12 trials sponsored. Other sponsors include 276 different institutions and companies that sponsored additional 147 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Tenon" #1 collaborator was "AstraZeneca" with 8 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 8 trials as a collaborator, "Ministry of Health, France" with 8 trials as a collaborator, "National Cancer Institute, France" with 8 trials as a collaborator and "Bristol-Myers Squibb" with 6 trials as a collaborator. Other collaborators include 233 different institutions and companies that were collaborators in the rest 187 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Tenon" are "Breast Cancer" (30 trials), "Prostate Cancer" (16 trials), "Colorectal Cancer" (14 trials), "HIV Infections" (11 trials) and "Ovarian Cancer" (10 trials). Many other conditions were trialed in "Hôpital Tenon" in a lesser frequency.

Most popular intervention types in "Hôpital Tenon" are "Drug" (231 trials), "Other" (72 trials), "Procedure" (57 trials), "Radiation" (29 trials) and "Device" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "fluorouracil" (20 trials), "radiation therapy" (17 trials), "oxaliplatin" (15 trials) and "gemcitabine hydrochloride" (13 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Tenon" are 296 trials for "All" genders, 76 trials for "Female" genders and 29 trials for "Male" genders.

Currently, there are 109 active trials in "Hôpital Tenon". 7 are not yet recruiting, 69 are recruiting, 32 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 208 completed trials in Hôpital Tenon, undefined suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Tenon, 11 "Phase 1" clinical trials were conducted, 101 "Phase 2" clinical trials and 128 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 75 trials that are defined as “Not Applicable".